Toxicologic Pathology now has a section devoted to laboratory animal pathology. This initiative will allow the journal to better address the ever-changing and multifaceted role of toxicologic pathologists in industry, government, and private practice. Particularly in smaller organizations, there are increasing requests for the toxicologic pathologist to offer opinions on laboratory animal medicine problems, especially in the area of spontaneous diseases, some of which may impact the outcome of toxicity and carcinogenicity studies. The recent occurrence of Helicobacter hepaticus infection and its potential to influence the liver tumor response in mice is a case in point (1). One means of bringing such relevant knowledge about spontaneous and newly emerging lab animal diseases to the readership is to include a section on laboratory animal pathology in the journal.
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The toxicologic pathologist is frequently called upon to comment on the utility of new animal models and their relevance to pharmacology and toxicology. Recent activity in exploring the utility of fish models in toxicity and carcinogenicity testing represents a specific example of newly emerging potential models (2) . Transgenic mice offer another lucrative area of research that should allow elucidation of mechanistic and molecular data to better interpret animal responses and to study human diseases in a relevant in vivo model. In this issue of Toxicologic Pathology, we have inaugurated a new column entitled &dquo;Highlights of Contemporary Transgenic Models,&dquo; with plans to include a new or useful transgenic model in each subsequent issue. It is hoped that this will help make the readership cognizant of the research potential of these models. In this issue, Dr. Greenberg describes a transgenic model for prostate cancer that mimics some of the pathogenesis and lesions of human prostate cancer. As this and similar transgenic models are introduced, characterized, and refined, we plan to bring these to the attention of the Toxicologic Pathology readership. In a future issue, we plan to highlight the ongoing validation of transgenic mouse models as an adjunct to carcinogenicity testing. We will present to the readership the ongoing status of joint efforts of a partnership involving the National Toxicology Program, the National Institute of Environmental Health Sciences, the Japanese Central Institute for Experimental Animals, several U.S. pharmaceutical companies, and European scientists in investigating use of 6-mo transgenic mouse studies in lieu of conventional 2-yr mouse carcinogenicity bioassays (see &dquo;1995 FDA Science Symposium,&dquo; elsewhere in this issue).
In the current scientific climate, there is increased emphasis on mechanistic studies to place the interpretation of laboratory animal toxicity and carcinogenicity responses into a more meaningful context, especially for regulatory purposes. Complex molecular biology measurements as well as more straight-forward cell kinetic studies are now frequently incorporated into conventional bioassays. The toxicologic pathologist is often asked about procedures to follow to permit collection of appropriate data for these mechanistic studies without compromising the traditional toxicity and histopathologic endpoints of these studies. For example, what is the best way to harvest tissues for oncogene analysis? What are the appropriate control tissues to collect for molecular biology studies? Does administration of bromodeoxyuridine in drinking water yield results similar to those from administration by osmotic minipump? These technical issues will also be featured in future issues of the journal to keep the readership up to date and informed.
Finally, we plan to consider occasional case reports of unique laboratory animal lesions that might be encountered in the practice of toxicologic pathology. In so doing, we will essentially begin to include some of the interests of our laboratory animal medicine colleagues in our journal. This case report material may emerge in the course of conducting toxicity and carcinogenicity studies, from monitoring laboratory animal colonies, and in the process of characterizing the spontaneous and treatment-related lesions in the large number of transgenic animals becoming available for research and testing purposes.
The comments and suggestions of the readership of Toxicologic Pathology as they relate to these plans are enthusiastically encouraged. 
